Skip to main content
PMC home page
Archives of Disease in Childhood logoLink to Archives of Disease in Childhood
. 2000 Sep;83(3):259–264. doi: 10.1136/adc.83.3.259

The use of immunosuppressive and cytotoxic drugs in non-malignant disease

P Brogan 1, M Dillon 1
PMCID: PMC1718468  PMID: 10952651

Full Text

The Full Text of this article is available as a PDF (110.2 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adu D., Pall A., Luqmani R. A., Richards N. T., Howie A. J., Emery P., Michael J., Savage C. O., Bacon P. A. Controlled trial of pulse versus continuous prednisolone and cyclophosphamide in the treatment of systemic vasculitis. QJM. 1997 Jun;90(6):401–409. doi: 10.1093/qjmed/90.6.401. [DOI] [PubMed] [Google Scholar]
  2. Austin H. A., 3rd, Klippel J. H., Balow J. E., le Riche N. G., Steinberg A. D., Plotz P. H., Decker J. L. Therapy of lupus nephritis. Controlled trial of prednisone and cytotoxic drugs. N Engl J Med. 1986 Mar 6;314(10):614–619. doi: 10.1056/NEJM198603063141004. [DOI] [PubMed] [Google Scholar]
  3. BRON K. M., STROTT C. A., SHAPIRO A. P. THE DIAGNOSTIC VALUE OF ANGIOGRAPHIC OBSERVATIONS IN POLYARTERITIS NODOSA. A CASE OF MULTIPLE ANEURYSMS IN THE VISCERAL ORGANS. Arch Intern Med. 1965 Sep;116:450–454. doi: 10.1001/archinte.1965.03870030130024. [DOI] [PubMed] [Google Scholar]
  4. Bansal V. K., Beto J. A. Treatment of lupus nephritis: a meta-analysis of clinical trials. Am J Kidney Dis. 1997 Feb;29(2):193–199. doi: 10.1016/s0272-6386(97)90029-9. [DOI] [PubMed] [Google Scholar]
  5. Barratt T. M., Cameron J. S., Chantler C., Ogg C. S., Soothill J. F. Comparative trial of 2 weeks and 8 weeks cyclophosphamide in steroid-sensitive relapsing nephrotic syndrome of childhood. Arch Dis Child. 1973 Apr;48(4):286–290. doi: 10.1136/adc.48.4.286. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Boumpas D. T., Austin H. A., 3rd, Vaughn E. M., Klippel J. H., Steinberg A. D., Yarboro C. H., Balow J. E. Controlled trial of pulse methylprednisolone versus two regimens of pulse cyclophosphamide in severe lupus nephritis. Lancet. 1992 Sep 26;340(8822):741–745. doi: 10.1016/0140-6736(92)92292-n. [DOI] [PubMed] [Google Scholar]
  7. Cameron J. S. Lupus nephritis in childhood and adolescence. Pediatr Nephrol. 1994 Apr;8(2):230–249. doi: 10.1007/BF00865490. [DOI] [PubMed] [Google Scholar]
  8. Daina E., Schieppati A., Remuzzi G. Mycophenolate mofetil for the treatment of Takayasu arteritis: report of three cases. Ann Intern Med. 1999 Mar 2;130(5):422–426. doi: 10.7326/0003-4819-130-5-199903020-00013. [DOI] [PubMed] [Google Scholar]
  9. David J., Vouyiouka O., Ansell B. M., Hall A., Woo P. Amyloidosis in juvenile chronic arthritis: a morbidity and mortality study. Clin Exp Rheumatol. 1993 Jan-Feb;11(1):85–90. [PubMed] [Google Scholar]
  10. Dev S., McCallum R. M., Jaffe G. J. Methotrexate treatment for sarcoid-associated panuveitis. Ophthalmology. 1999 Jan;106(1):111–118. doi: 10.1016/S0161-6420(99)90011-8. [DOI] [PubMed] [Google Scholar]
  11. Dillon M. J. Childhood vasculitis. Lupus. 1998;7(4):259–265. doi: 10.1191/096120398678920064. [DOI] [PubMed] [Google Scholar]
  12. Elhence R., Gulati S., Kher V., Gupta A., Sharma R. K. Intravenous pulse cyclophosphamide--a new regime for steroid-resistant minimal change nephrotic syndrome. Pediatr Nephrol. 1994 Feb;8(1):1–3. doi: 10.1007/BF00868243. [DOI] [PubMed] [Google Scholar]
  13. Fauci A. S., Katz P., Haynes B. F., Wolff S. M. Cyclophosphamide therapy of severe systemic necrotizing vasculitis. N Engl J Med. 1979 Aug 2;301(5):235–238. doi: 10.1056/NEJM197908023010503. [DOI] [PubMed] [Google Scholar]
  14. Feagan B. G., Rochon J., Fedorak R. N., Irvine E. J., Wild G., Sutherland L., Steinhart A. H., Greenberg G. R., Gillies R., Hopkins M. Methotrexate for the treatment of Crohn's disease. The North American Crohn's Study Group Investigators. N Engl J Med. 1995 Feb 2;332(5):292–297. doi: 10.1056/NEJM199502023320503. [DOI] [PubMed] [Google Scholar]
  15. Fickert P., Hinterleitner T. A., Wenzl H. H., Aichbichler B. W., Petritsch W. Mycophenolate mofetil in patients with Crohn's disease. Am J Gastroenterol. 1998 Dec;93(12):2529–2532. doi: 10.1111/j.1572-0241.1998.00606.x. [DOI] [PubMed] [Google Scholar]
  16. Giannini E. H., Brewer E. J., Kuzmina N., Shaikov A., Maximov A., Vorontsov I., Fink C. W., Newman A. J., Cassidy J. T., Zemel L. S. Methotrexate in resistant juvenile rheumatoid arthritis. Results of the U.S.A.-U.S.S.R. double-blind, placebo-controlled trial. The Pediatric Rheumatology Collaborative Study Group and The Cooperative Children's Study Group. N Engl J Med. 1992 Apr 16;326(16):1043–1049. doi: 10.1056/NEJM199204163261602. [DOI] [PubMed] [Google Scholar]
  17. Goonasekera C. D., Koziell A. B., Hulton S. A., Dillon M. J. Vincristine and focal segmental sclerosis: do we need a multicentre trial? Pediatr Nephrol. 1998 May;12(4):284–289. doi: 10.1007/s004670050454. [DOI] [PubMed] [Google Scholar]
  18. Hall S., Barr W., Lie J. T., Stanson A. W., Kazmier F. J., Hunder G. G. Takayasu arteritis. A study of 32 North American patients. Medicine (Baltimore) 1985 Mar;64(2):89–99. [PubMed] [Google Scholar]
  19. Haubitz M., Ehlerding C., Kamino K., Koch K. M., Brunkhorst R. Reduced gonadal toxicity after i.v. cyclophosphamide administration in patients with nonmalignant diseases. Clin Nephrol. 1998 Jan;49(1):19–23. [PubMed] [Google Scholar]
  20. Haubitz M., Schellong S., Göbel U., Schurek H. J., Schaumann D., Koch K. M., Brunkhorst R. Intravenous pulse administration of cyclophosphamide versus daily oral treatment in patients with antineutrophil cytoplasmic antibody-associated vasculitis and renal involvement: a prospective, randomized study. Arthritis Rheum. 1998 Oct;41(10):1835–1844. doi: 10.1002/1529-0131(199810)41:10<1835::AID-ART16>3.0.CO;2-Q. [DOI] [PubMed] [Google Scholar]
  21. Hay E. M., Bacon P. A., Gordon C., Isenberg D. A., Maddison P., Snaith M. L., Symmons D. P., Viner N., Zoma A. The BILAG index: a reliable and valid instrument for measuring clinical disease activity in systemic lupus erythematosus. Q J Med. 1993 Jul;86(7):447–458. [PubMed] [Google Scholar]
  22. Heckmatt J., Hasson N., Saunders C., Thompson N., Peters A. M., Cambridge G., Rose M., Hyde S. A., Dubowitz V. Cyclosporin in juvenile dermatomyositis. Lancet. 1989 May 13;1(8646):1063–1066. doi: 10.1016/s0140-6736(89)92456-2. [DOI] [PubMed] [Google Scholar]
  23. Hunder G. G. The use and misuse of classification and diagnostic criteria for complex diseases. Ann Intern Med. 1998 Sep 1;129(5):417–418. doi: 10.7326/0003-4819-129-5-199809010-00013. [DOI] [PubMed] [Google Scholar]
  24. Jackson L. D., Song E. Cyclosporin in the treatment of corticosteroid resistant autoimmune chronic active hepatitis. Gut. 1995 Mar;36(3):459–461. doi: 10.1136/gut.36.3.459. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Jardim H. M., Leake J., Risdon R. A., Barratt T. M., Dillon M. J. Crescentic glomerulonephritis in children. Pediatr Nephrol. 1992 May;6(3):231–235. doi: 10.1007/BF00878354. [DOI] [PubMed] [Google Scholar]
  26. Jorizzo J. L., Schmalstieg F. C., Solomon A. R., Jr, Cavallo T., Taylor R. S., 3rd, Rudloff H. B., Schmalstieg E. J., Daniels J. C. Thalidomide effects in Behçet's syndrome and pustular vasculitis. Arch Intern Med. 1986 May;146(5):878–881. [PubMed] [Google Scholar]
  27. Kvien T. K., Høyeraal H. M., Sandstad B. Azathioprine versus placebo in patients with juvenile rheumatoid arthritis: a single center double blind comparative study. J Rheumatol. 1986 Feb;13(1):118–123. [PubMed] [Google Scholar]
  28. Langford C. A., Klippel J. H., Balow J. E., James S. P., Sneller M. C. Use of cytotoxic agents and cyclosporine in the treatment of autoimmune disease. Part 1: rheumatologic and renal diseases. Ann Intern Med. 1998 Jun 15;128(12 Pt 1):1021–1028. doi: 10.7326/0003-4819-128-12_part_1-199806150-00012. [DOI] [PubMed] [Google Scholar]
  29. Langford C. A., Klippel J. H., Balow J. E., James S. P., Sneller M. C. Use of cytotoxic agents and cyclosporine in the treatment of autoimmune disease. Part 2: Inflammatory bowel disease, systemic vasculitis, and therapeutic toxicity. Ann Intern Med. 1998 Jul 1;129(1):49–58. doi: 10.7326/0003-4819-129-1-199807010-00012. [DOI] [PubMed] [Google Scholar]
  30. Lightfoot R. W., Jr, Michel B. A., Bloch D. A., Hunder G. G., Zvaifler N. J., McShane D. J., Arend W. P., Calabrese L. H., Leavitt R. Y., Lie J. T. The American College of Rheumatology 1990 criteria for the classification of polyarteritis nodosa. Arthritis Rheum. 1990 Aug;33(8):1088–1093. doi: 10.1002/art.1780330805. [DOI] [PubMed] [Google Scholar]
  31. Luqmani R. A., Bacon P. A., Moots R. J., Janssen B. A., Pall A., Emery P., Savage C., Adu D. Birmingham Vasculitis Activity Score (BVAS) in systemic necrotizing vasculitis. QJM. 1994 Nov;87(11):671–678. [PubMed] [Google Scholar]
  32. Maggiore G., Bernard O., Hadchouel M., Hadchouel P., Odievre M., Alagille D. Treatment of autoimmune chronic active hepatitis in childhood. J Pediatr. 1984 Jun;104(6):839–844. doi: 10.1016/s0022-3476(84)80477-1. [DOI] [PubMed] [Google Scholar]
  33. Masuda K., Nakajima A., Urayama A., Nakae K., Kogure M., Inaba G. Double-masked trial of cyclosporin versus colchicine and long-term open study of cyclosporin in Behçet's disease. Lancet. 1989 May 20;1(8647):1093–1096. doi: 10.1016/s0140-6736(89)92381-7. [DOI] [PubMed] [Google Scholar]
  34. McCurdy D. K., Lehman T. J., Bernstein B., Hanson V., King K. K., Nadorra R., Landing B. H. Lupus nephritis: prognostic factors in children. Pediatrics. 1992 Feb;89(2):240–246. [PubMed] [Google Scholar]
  35. McLain L. G., Kelsch R. C., Bookstein J. J. Polyarteritis nodosa diagnosed by renal arteriography. J Pediatr. 1972 Jun;80(6):1032–1035. doi: 10.1016/s0022-3476(72)80022-2. [DOI] [PubMed] [Google Scholar]
  36. Nakata S., Uematsu K., Mori T., Mitsushita N., Kinoshita T., Ishioka C., Mutou K., Yokota S., Hirose Y., Komiyama A. Effective treatment with low-dose methotrexate pulses of a child of mixed connective tissue disease with severe myositis refractory to corticosteroid. Nihon Rinsho Meneki Gakkai Kaishi. 1997 Jun;20(3):178–183. doi: 10.2177/jsci.20.178. [DOI] [PubMed] [Google Scholar]
  37. Neary C., Wilkins A. J. Effects of phosphor persistence on perception and the control of eye movements. Perception. 1989;18(2):257–264. doi: 10.1068/p180257. [DOI] [PubMed] [Google Scholar]
  38. O'Duffy J. D., Goldstein N. P. Neurologic involvement in seven patients with Behçet's disease. Am J Med. 1976 Aug;61(2):170–178. doi: 10.1016/0002-9343(76)90166-2. [DOI] [PubMed] [Google Scholar]
  39. Palmer R. G., Kanski J. J., Ansell B. M. Chlorambucil in the treatment of intractable Uveitis associated with juvenile chronic arthritis. J Rheumatol. 1985 Oct;12(5):967–970. [PubMed] [Google Scholar]
  40. Pearson D. C., May G. R., Fick G. H., Sutherland L. R. Azathioprine and 6-mercaptopurine in Crohn disease. A meta-analysis. Ann Intern Med. 1995 Jul 15;123(2):132–142. doi: 10.7326/0003-4819-123-2-199507150-00009. [DOI] [PubMed] [Google Scholar]
  41. Pistoia V., Buoncompagni A., Scribanis R., Fasce L., Alpigiani G., Cordone G., Ferrarini M., Borrone C., Cottafava F. Cyclosporin A in the treatment of juvenile chronic arthritis and childhood polymyositis-dermatomyositis. Results of a preliminary study. Clin Exp Rheumatol. 1993 Mar-Apr;11(2):203–208. [PubMed] [Google Scholar]
  42. Pivetti-Pezzi P., Accorinti M., Abdulaziz M. A., La Cava M., Torella M., Riso D. Behçets disease in children. Jpn J Ophthalmol. 1995;39(3):309–314. [PubMed] [Google Scholar]
  43. Ponticelli C., Rizzoni G., Edefonti A., Altieri P., Rivolta E., Rinaldi S., Ghio L., Lusvarghi E., Gusmano R., Locatelli F. A randomized trial of cyclosporine in steroid-resistant idiopathic nephrotic syndrome. Kidney Int. 1993 Jun;43(6):1377–1384. doi: 10.1038/ki.1993.194. [DOI] [PubMed] [Google Scholar]
  44. Ravelli A., Viola S., Migliavacca D., Ruperto N., Pistorio A., Martini A. The extended oligoarticular subtype is the best predictor of methotrexate efficacy in juvenile idiopathic arthritis. J Pediatr. 1999 Sep;135(3):316–320. doi: 10.1016/s0022-3476(99)70127-7. [DOI] [PubMed] [Google Scholar]
  45. Rottem M., Fauci A. S., Hallahan C. W., Kerr G. S., Lebovics R., Leavitt R. Y., Hoffman G. S. Wegener granulomatosis in children and adolescents: clinical presentation and outcome. J Pediatr. 1993 Jan;122(1):26–31. doi: 10.1016/s0022-3476(05)83482-1. [DOI] [PubMed] [Google Scholar]
  46. Savage C. O., Winearls C. G., Evans D. J., Rees A. J., Lockwood C. M. Microscopic polyarteritis: presentation, pathology and prognosis. Q J Med. 1985 Aug;56(220):467–483. [PubMed] [Google Scholar]
  47. Savolainen H. A., Kautiainen H., Isomäki H., Aho K., Verronen P. Azathioprine in patients with juvenile chronic arthritis: a longterm followup study. J Rheumatol. 1997 Dec;24(12):2444–2450. [PubMed] [Google Scholar]
  48. See Y., Martin K., Rooney M., Woo P. Severe juvenile dermatomyositis complicated by pancreatitis. Br J Rheumatol. 1997 Aug;36(8):912–916. doi: 10.1093/rheumatology/36.8.912. [DOI] [PubMed] [Google Scholar]
  49. Shaikov A. V., Maximov A. A., Speransky A. I., Lovell D. J., Giannini E. H., Solovyev S. K. Repetitive use of pulse therapy with methylprednisolone and cyclophosphamide in addition to oral methotrexate in children with systemic juvenile rheumatoid arthritis--preliminary results of a longterm study. J Rheumatol. 1992 Apr;19(4):612–616. [PubMed] [Google Scholar]
  50. Shelhamer J. H., Volkman D. J., Parrillo J. E., Lawley T. J., Johnston M. R., Fauci A. S. Takayasu's arteritis and its therapy. Ann Intern Med. 1985 Jul;103(1):121–126. doi: 10.7326/0003-4819-103-1-121. [DOI] [PubMed] [Google Scholar]
  51. Tarshish P., Tobin J. N., Bernstein J., Edelmann C. M., Jr Cyclophosphamide does not benefit patients with focal segmental glomerulosclerosis. A report of the International Study of Kidney Disease in Children. Pediatr Nephrol. 1996 Oct;10(5):590–593. doi: 10.1007/s004670050167. [DOI] [PubMed] [Google Scholar]
  52. Trompeter R. S., Evans P. R., Barratt T. M. Gonadal function in boys with steroid-responsive nephrotic syndrome treated with cyclophosphamide for short periods. Lancet. 1981 May 30;1(8231):1177–1179. doi: 10.1016/s0140-6736(81)92348-5. [DOI] [PubMed] [Google Scholar]
  53. Van Thiel D. H., Wright H., Carroll P., Abu-Elmagd K., Rodriguez-Rilo H., McMichael J., Irish W., Starzl T. E. Tacrolimus: a potential new treatment for autoimmune chronic active hepatitis: results of an open-label preliminary trial. Am J Gastroenterol. 1995 May;90(5):771–776. [PMC free article] [PubMed] [Google Scholar]
  54. Wiggelinkhuizen J., Cremin B. J. Takayasu arteritis and renovascular hypertension in childhood. Pediatrics. 1978 Aug;62(2):209–217. [PubMed] [Google Scholar]
  55. Yang L. Y., Chen W. P., Lin C. Y. Lupus nephritis in children--a review of 167 patients. Pediatrics. 1994 Sep;94(3):335–340. [PubMed] [Google Scholar]
  56. Zuber M., Defer G., Cesaro P., Degos J. D. Efficacy of cyclophosphamide in sarcoid radiculomyelitis. J Neurol Neurosurg Psychiatry. 1992 Feb;55(2):166–167. doi: 10.1136/jnnp.55.2.166-a. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood are provided here courtesy of BMJ Publishing Group

RESOURCES